The Annals of Hepatology welcomes the Canadian Association for the Study of the Liver (CASL)

Treatment issues surrounding hepatitis C in renal transplantation: A review

Hepatitis C infection is prevalent in candidates for and recipients of solid organ transplants. In the renal transplant population, HCV infection has been shown to decrease long-term patient and graft survival. The outco...

High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation

Background. Liver re-transplantation (re-OLT) remains the only feasible option for patients with graft failure following liver transplantation. Sparse resources and a growing waitlist mandate that available grafts are a...

Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects

Background & aims. Studies about the natural history of hepatitis C virus (HCV) infection report variable progression to cirrhosis depending on study design. Retrospective cross-sectional liver clinic studie...

Utility and safety of tolvaptan in cirrhotic patients with hyponatremia: A prospective cohort study

[sup][/sup] Introduction and aim. Hyponatremia is common in patients with decompensated cirrhosis and is associated with increased mortality. Tolvaptan, a vasopressor V2 receptor antagonist, can increase free water excre...